Insights

Why Albemarle’s Stock Flew Higher This Week

What happened
After slumping through April, shares of Albemarle (NYSE: ALB) got off to a roaring start in May. Beyond its strong first quarter 2022 earnings report, management’s auspicious 2022 forecast and enthusiasm from analysts for the lithium stock had investors clicking the buy button this week.
From the end of trading last week through the close on Friday, shares of Albemarle skyrocketed by 25.8%, according to data provided by S&P Global Market Intelligence.
So what
Albemarle reported Q1 2022 revenue of $1.13 billion and earnings per share (EPS) of $2.38. Analysts had estimated the company would report sales of $1.02 billion and EPS of $1.63.
Image source: Getty Images.

The company’s strong performance was also visible with regard to its year-over-year growth: Sales rose by 36%, and diluted EPS rose by 156%. 
Management’s optimistic view of what lies ahead also delighted investors. Initially, Albemarle had forecast 2022 revenue in the $4.2 billion to $4.5 billion range; however, it now anticipates sales in the $5.2 billion to $5.6 billion range. Similarly, the company is now forecasting 2022 adjusted diluted EPS of $9.25 to $12.25 — up from its original guidance range of $5.65 to $6.65.
A tide of bullish sentiment among analysts also helped propel the stock’s rise this week.
Citigroup raised its price target on Albemarle from $262 to $279.
Mizuho lifted its price target from $243 to $293.
Deutsche Bank hiked its price target from $250 to $290.
Now what
Albemarle is one of the most popular lithium stocks, so the attention that bulls paid it this week is unsurprising. For those considering charging up their returns by adding the stock to their portfolios now, however, it may be worth exercising some patience. After its run-up, the stock trades at a lofty valuation of 70.9 times operating cash flow, a hefty premium to its five-year average ratio of 24.1.
Citigroup is an advertising partner of The Ascent, a Motley Fool company. Scott Levine has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. –

What happened

After slumping through April, shares of Albemarle (NYSE: ALB) got off to a roaring start in May. Beyond its strong first quarter 2022 earnings report, management’s auspicious 2022 forecast and enthusiasm from analysts for the lithium stock had investors clicking the buy button this week.

From the end of trading last week through the close on Friday, shares of Albemarle skyrocketed by 25.8%, according to data provided by S&P Global Market Intelligence.

So what

Albemarle reported Q1 2022 revenue of $1.13 billion and earnings per share (EPS) of $2.38. Analysts had estimated the company would report sales of $1.02 billion and EPS of $1.63.

Image source: Getty Images.

The company’s strong performance was also visible with regard to its year-over-year growth: Sales rose by 36%, and diluted EPS rose by 156%. 

Management’s optimistic view of what lies ahead also delighted investors. Initially, Albemarle had forecast 2022 revenue in the $4.2 billion to $4.5 billion range; however, it now anticipates sales in the $5.2 billion to $5.6 billion range. Similarly, the company is now forecasting 2022 adjusted diluted EPS of $9.25 to $12.25 — up from its original guidance range of $5.65 to $6.65.

A tide of bullish sentiment among analysts also helped propel the stock’s rise this week.

Citigroup raised its price target on Albemarle from $262 to $279.
Mizuho lifted its price target from $243 to $293.
Deutsche Bank hiked its price target from $250 to $290.

Now what

Albemarle is one of the most popular lithium stocks, so the attention that bulls paid it this week is unsurprising. For those considering charging up their returns by adding the stock to their portfolios now, however, it may be worth exercising some patience. After its run-up, the stock trades at a lofty valuation of 70.9 times operating cash flow, a hefty premium to its five-year average ratio of 24.1.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Scott Levine has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!